Navegando por Palavras-chave "oral appliances"

Agora exibindo 1 - 2 de 2
  • Nenhuma Miniatura disponível
    Item
    Somente Metadadados
    Different approaches to dental management of self-inflicted oral trauma: Oral shield, botulinum toxin type A neuromuscular block, and oral surgery
    (Quintessence Publishing Co Inc, 2008-02-01) Santos, Maria Teresa Botti Rodrigues; Manzano, Felipe Scalco [UNIFESP]; Genovese, Walter Joao; Univ Cruzeiro Sul; Universidade Federal de São Paulo (UNIFESP)
    Objective: To assess different approaches to the dental management of lip injuries caused by self-inflicted oral trauma in 7 patients. Method and Materials: The patients were grouped based on 3 treatment approaches: group 1, placement of an oral appliance; group 2, botulinum toxin type A neuromuscular block; and group 3, oral surgery. Results and Conclusion: Neuromuscular block can be the first choice of treatment for patients with self-injurious behavior since botulinum toxin A injection is a well-tolerated, safe, and effective procedure, permitting improvement in muscle spasticity, bruxism, range of mouth opening, oral hygiene, and lip trauma. The second option would be the use of the oral appliance, and the last choice is oral surgery. Laser therapy was also found to be effective when applied to traumatic injuries in patients who present self-inflicted oral trauma.
  • Nenhuma Miniatura disponível
    Item
    Somente Metadadados
    Titratable mandibular repositioner appliances for obstructive sleep apnea syndrome: are they an option?
    (Springer, 2007-12-01) Machado, Marco Antonio Cardoso; Juliano, Ligia; Taga, Marcel; Carvalho, Luciane Bizari Coin de; Prado, Lucila Bizari Fernandes do; Prado, Gilmar Fernandes do; Universidade Federal de São Paulo (UNIFESP)
    Mandibular repositioning appliances (tMRAs) designed with a titratable mechanism are effective to treat obstructive sleep apnea syndrome (OSAS) but are not widely used, although many studies have proven their value. the aim of the present study was to evaluate the efficacy of tMRAs in the treatment of OSAS on the criteria of the American Academy of Sleep Medicine (AASM; apnea/hypopnea index [AHI]< 5). Three hundred consecutive patients with a polysomnographic diagnosis of OSAS were referred for treatment with tMRAs between 2000 and 2003. Thirty-eight patients were excluded, and 262 concluded the titration protocol with tMRA that lasted 4 months. After titration, the patients were referred for a medical reassessment, and 83 patients (70 men) participated in the new polysomnographic exam with tMRA in place to access tMRA's efficacy. the mean pre- and post-treatment AHI were 26 +/- 17.7 and 4.8 +/- 5.3 events per hour, respectively (p < 0.00005). Fifty-three (62.6%) of the 83 patients were treated successfully (AHI < 5). Twenty-three patients had severe OSAS, and 12 of them (52.1%) were treated successfully (AHI < 5). Forty patients had moderate OSAS, and 26 of them (65%) were treated successfully. Twenty patients had mild OSAS, and 15 (75%) were successfully treated. Even when applying more rigid criteria such as those of the AASM, the expressive success rate obtained with the treatment of different degrees of OSAS indicates that tMRAs are an additional valuable option even for cases of severe apnea in which the patient does not tolerate continuous positive airway pressure or cannot afford this treatment, a fact quite common in Brazil and other developing countries.